BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang X, Li M, Wang Z, Han S, Tang X, Ge Y, Zhou L, Zhou C, Yuan Q, Yang M. Silencing of long noncoding RNA MALAT1 by miR-101 and miR-217 inhibits proliferation, migration, and invasion of esophageal squamous cell carcinoma cells. J Biol Chem. 2015;290:3925-3935. [PMID: 25538231 DOI: 10.1074/jbc.m114.596866] [Cited by in Crossref: 197] [Cited by in F6Publishing: 127] [Article Influence: 24.6] [Reference Citation Analysis]
Number Citing Articles
1 Hou X, Wen J, Ren Z, Zhang G. Non-coding RNAs: new biomarkers and therapeutic targets for esophageal cancer. Oncotarget 2017;8:43571-8. [PMID: 28388588 DOI: 10.18632/oncotarget.16721] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
2 Su S, Wang Y, Wang H, Huang W, Chen J, Xing J, Xu P, Yuan X, Huang C, Zhou Y. Comparative expression analysis identifies the respiratory transition-related miRNAs and their target genes in tissues of metamorphosing Chinese giant salamander (Andrias davidianus). BMC Genomics 2018;19:406. [PMID: 29843595 DOI: 10.1186/s12864-018-4662-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
3 Jin Y, Qi G, Chen G, Wang C, Fan X. Association between B-Myb proto-oncogene and the development of malignant tumors. Oncol Lett 2021;21:166. [PMID: 33552284 DOI: 10.3892/ol.2021.12427] [Reference Citation Analysis]
4 Hamidi AA, Zangoue M, Kashani D, Zangouei AS, Rahimi HR, Abbaszadegan MR, Moghbeli M. MicroRNA-217: a therapeutic and diagnostic tumor marker. Expert Rev Mol Diagn 2021;:1-16. [PMID: 34883033 DOI: 10.1080/14737159.2022.2017284] [Reference Citation Analysis]
5 Cai Y, Li X, Shen P, Zhang D. CCAT2 is an oncogenic long non-coding RNA in pancreatic ductal adenocarcinoma. Biol Res 2018;51:1. [PMID: 29298720 DOI: 10.1186/s40659-017-0149-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
6 Yang R, Shui Y, Hu S, Zhang K, Wang Y, Peng Y. Silenced Myeloblastosis Protein Suppresses Oral Tongue Squamous Cell Carcinoma via the microRNA-130a/Cylindromatosis Axis. Cancer Manag Res 2020;12:6935-46. [PMID: 32821162 DOI: 10.2147/CMAR.S252340] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Pan W, Zhang N, Liu W, Liu J, Zhou L, Liu Y, Yang M. The long noncoding RNA GAS8-AS1 suppresses hepatocarcinogenesis by epigenetically activating the tumor suppressor GAS8. J Biol Chem. 2018;293:17154-17165. [PMID: 30228180 DOI: 10.1074/jbc.ra118.003055] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
8 Ren Y, Shang J, Li J, Liu W, Zhang Z, Yuan J, Yang M. The long noncoding RNA PCAT-1 links the microRNA miR-215 to oncogene CRKL-mediated signaling in hepatocellular carcinoma. J Biol Chem 2017;292:17939-49. [PMID: 28887306 DOI: 10.1074/jbc.M116.773978] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
9 Wang R, Zheng B, Liu H, Wan X. Long non-coding RNA PCAT1 drives clear cell renal cell carcinoma by upregulating YAP via sponging miR-656 and miR-539. Cell Cycle 2020;19:1122-31. [PMID: 32286142 DOI: 10.1080/15384101.2020.1748949] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
10 Xiang J, Guo S, Jiang S, Xu Y, Li J, Li L, Xiang J. Silencing of Long Non-Coding RNA MALAT1 Promotes Apoptosis of Glioma Cells. J Korean Med Sci 2016;31:688-94. [PMID: 27134488 DOI: 10.3346/jkms.2016.31.5.688] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 5.5] [Reference Citation Analysis]
11 Mei D, Zhu Y, Zhang L, Wei W. The Role of CTHRC1 in Regulation of Multiple Signaling and Tumor Progression and Metastasis. Mediators Inflamm 2020;2020:9578701. [PMID: 32848510 DOI: 10.1155/2020/9578701] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
12 Silva A, Bullock M, Calin G. The Clinical Relevance of Long Non-Coding RNAs in Cancer. Cancers (Basel). 2015;7:2169-2182. [PMID: 26516918 DOI: 10.3390/cancers7040884] [Cited by in Crossref: 83] [Cited by in F6Publishing: 84] [Article Influence: 11.9] [Reference Citation Analysis]
13 Xiong M, Wu M, Dan Peng, Huang W, Chen Z, Ke H, Chen Z, Song W, Zhao Y, Xiang AP, Zhong X. LncRNA DANCR represses Doxorubicin-induced apoptosis through stabilizing MALAT1 expression in colorectal cancer cells. Cell Death Dis 2021;12:24. [PMID: 33414433 DOI: 10.1038/s41419-020-03318-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Chen J, Liu S, Hu X. Long non-coding RNAs: crucial regulators of gastrointestinal cancer cell proliferation. Cell Death Discov 2018;4:50. [PMID: 29736267 DOI: 10.1038/s41420-018-0051-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 5.5] [Reference Citation Analysis]
15 Liu Q, Zheng S, Chen Y, Liu T, Han X, Zhang X, Shen T, Lu X. TGF-β1-Induced Upregulation of MALAT1 Promotes Kazakh's Esophageal Squamous Cell Carcinoma Invasion by EMT. J Cancer 2020;11:6892-901. [PMID: 33123280 DOI: 10.7150/jca.48426] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Shi M, Xia J, Xing H, Yang W, Xiong X, Pan W, Han S, Shang J, Zhou C, Zhou L, Yang M. The Sp1-mediaded allelic regulation of MMP13 expression by an ESCC susceptibility SNP rs2252070. Sci Rep 2016;6:27013. [PMID: 27245877 DOI: 10.1038/srep27013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
17 Zhang X, Zhang X, Shen L, Song L, Wu J, Cao G, Chen X, Zhu B. Comprehensive analysis of differentially expressed lncRNAs as diagnostic and prognostic markers for colorectal cancer. Exp Ther Med 2019;18:4481-9. [PMID: 31772638 DOI: 10.3892/etm.2019.8067] [Reference Citation Analysis]
18 Wang Y, Zhang Y, Yang T, Zhao W, Wang N, Li P, Zeng X, Zhang W. Long non-coding RNA MALAT1 for promoting metastasis and proliferation by acting as a ceRNA of miR-144-3p in osteosarcoma cells. Oncotarget. 2017;8:59417-59434. [PMID: 28938647 DOI: 10.18632/oncotarget.19727] [Cited by in Crossref: 79] [Cited by in F6Publishing: 85] [Article Influence: 15.8] [Reference Citation Analysis]
19 Wang X, Sehgal L, Jain N, Khashab T, Mathur R, Samaniego F. LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2. J Transl Med 2016;14:346. [PMID: 27998273 DOI: 10.1186/s12967-016-1100-9] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 8.0] [Reference Citation Analysis]
20 Zhang Y, Chen WJ, Gan TQ, Zhang XL, Xie ZC, Ye ZH, Deng Y, Wang ZF, Cai KT, Li SK, Luo DZ, Chen G. Clinical Significance and Effect of lncRNA HOXA11-AS in NSCLC: A Study Based on Bioinformatics, In Vitro and in Vivo Verification. Sci Rep 2017;7:5567. [PMID: 28717185 DOI: 10.1038/s41598-017-05856-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 32] [Article Influence: 5.2] [Reference Citation Analysis]
21 Liu Z, Liu J, Wei Y, Xu J, Wang Z, Wang P, Sun H, Song Z, Liu Q. LncRNA MALAT1 prevents the protective effects of miR-125b-5p against acute myocardial infarction through positive regulation of NLRC5. Exp Ther Med 2020;19:990-8. [PMID: 32010261 DOI: 10.3892/etm.2019.8309] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
22 Zhang F, Cai Y, Diao B, Song D, Miao R, Zhang B, Hu Y, Zeng H, Hu X. Long Non-Coding RNA NLIPMT as a Tumor Suppressor and Inhibitor of Cell Proliferation and Metastasis in Papillary Thyroid Carcinoma. Cancer Manag Res 2020;12:10311-9. [PMID: 33116886 DOI: 10.2147/CMAR.S266807] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Li J, Cui Z, Li H, Lv X, Gao M, Yang Z, Bi Y, Zhang Z, Wang S, Zhou B, Yin Z. Clinicopathological and prognostic significance of long noncoding RNA MALAT1 in human cancers: a review and meta-analysis. Cancer Cell Int 2018;18:109. [PMID: 30093838 DOI: 10.1186/s12935-018-0606-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
24 Li Z, Xu C, Ding B, Gao M, Wei X, Ji N. Long non-coding RNA MALAT1 promotes proliferation and suppresses apoptosis of glioma cells through derepressing Rap1B by sponging miR-101. J Neurooncol 2017;134:19-28. [PMID: 28551849 DOI: 10.1007/s11060-017-2498-5] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 9.4] [Reference Citation Analysis]
25 Liu X, Lv R, Zhang L, Xu G, Bi J, Gao F, Zhang J, Xue F, Wang F, Wu Y, Fu C, Wang Q, Huo R. Long noncoding RNA expression profile of infantile hemangioma identified by microarray analysis. Tumour Biol 2016. [PMID: 27709553 DOI: 10.1007/s13277-016-5434-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
26 Huang X, Pan J, Wang G, Huang T, Li C, Wang Y, Li X. UNC5B-AS1 promotes the proliferation, migration and EMT of hepatocellular carcinoma cells via regulating miR-4306/KDM2A axis. Cell Cycle 2021;20:2114-24. [PMID: 34612138 DOI: 10.1080/15384101.2021.1962632] [Reference Citation Analysis]
27 Hua WF, Zhong Q, Xia TL, Chen Q, Zhang MY, Zhou AJ, Tu ZW, Qu C, Li MZ, Xia YF, Wang HY, Xie D, Claret FX, Song EW, Zeng MS. RBM24 suppresses cancer progression by upregulating miR-25 to target MALAT1 in nasopharyngeal carcinoma. Cell Death Dis 2016;7:e2352. [PMID: 27584791 DOI: 10.1038/cddis.2016.252] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 7.0] [Reference Citation Analysis]
28 Wang W, Zhu Y, Li S, Chen X, Jiang G, Shen Z, Qiao Y, Wang L, Zheng P, Zhang Y. Long noncoding RNA MALAT1 promotes malignant development of esophageal squamous cell carcinoma by targeting β-catenin via Ezh2. Oncotarget 2016;7:25668-82. [PMID: 27015363 DOI: 10.18632/oncotarget.8257] [Cited by in Crossref: 57] [Cited by in F6Publishing: 65] [Article Influence: 14.3] [Reference Citation Analysis]
29 Ren ZP, Hou XB, Tian XD, Guo JT, Zhang LB, Xue ZQ, Deng JQ, Zhang SW, Pan JY, Chu XY. Identification of nine microRNAs as potential biomarkers for lung adenocarcinoma. FEBS Open Bio 2019;9:315-27. [PMID: 30761256 DOI: 10.1002/2211-5463.12572] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
30 Jia L, Zhang D, Huang H, Zhou Y, Zhou S, Guo J. Triazophos-induced toxicity in zebrafish: miRNA-217 inhibits nup43. Toxicol Res (Camb) 2018;7:913-22. [PMID: 30310668 DOI: 10.1039/c8tx00065d] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Zhao ZB, Chen F, Bai XF. Long Noncoding RNA MALAT1 Regulates Hepatocellular Carcinoma Growth Under Hypoxia via Sponging MicroRNA-200a. Yonsei Med J 2019;60:727-34. [PMID: 31347327 DOI: 10.3349/ymj.2019.60.8.727] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
32 Xuan Z, Feng X, Yu J, Ping P, Zhao H, Zhu X, Wang L. A Novel Method for Predicting Disease-Associated LncRNA-MiRNA Pairs Based on the Higher-Order Orthogonal Iteration. Comput Math Methods Med 2019;2019:7614850. [PMID: 31191710 DOI: 10.1155/2019/7614850] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
33 Tang WW, Wu Q, Li SQ, Tong YS, Liu ZH, Yang TX, Xu Y, Cao XF. Implication of lncRNAs in pathogenesis of esophageal cancer. Onco Targets Ther 2015;8:3219-26. [PMID: 26609239 DOI: 10.2147/OTT.S87856] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
34 Sun H, Tian J, Xian W, Xie T, Yang X. miR-34a inhibits proliferation and invasion of bladder cancer cells by targeting orphan nuclear receptor HNF4G. Dis Markers 2015;2015:879254. [PMID: 25878394 DOI: 10.1155/2015/879254] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
35 Harada K, Baba Y, Ishimoto T, Shigaki H, Kosumi K, Yoshida N, Watanabe M, Baba H. The role of microRNA in esophageal squamous cell carcinoma. J Gastroenterol. 2016;51:520-530. [PMID: 26794004 DOI: 10.1007/s00535-016-1161-9] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 5.8] [Reference Citation Analysis]
36 Amodio N, Raimondi L, Juli G, Stamato MA, Caracciolo D, Tagliaferri P, Tassone P. MALAT1: a druggable long non-coding RNA for targeted anti-cancer approaches. J Hematol Oncol 2018;11:63. [PMID: 29739426 DOI: 10.1186/s13045-018-0606-4] [Cited by in Crossref: 123] [Cited by in F6Publishing: 119] [Article Influence: 30.8] [Reference Citation Analysis]
37 Kazimierczyk M, Kasprowicz MK, Kasprzyk ME, Wrzesinski J. Human Long Noncoding RNA Interactome: Detection, Characterization and Function. Int J Mol Sci 2020;21:E1027. [PMID: 32033158 DOI: 10.3390/ijms21031027] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 19.5] [Reference Citation Analysis]
38 Joshi M, Rajender S. Long non-coding RNAs (lncRNAs) in spermatogenesis and male infertility. Reprod Biol Endocrinol 2020;18:103. [PMID: 33126901 DOI: 10.1186/s12958-020-00660-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
39 Xu E, Liang X, Ji Z, Zhao S, Li L, Lang J. Blocking long noncoding RNA MALAT1 restrained the development of laryngeal and hypopharyngeal carcinoma. Eur Arch Otorhinolaryngol 2020;277:611-21. [PMID: 31792655 DOI: 10.1007/s00405-019-05732-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
40 Li FZ, Zang WQ. Knockdown of lncRNAXLOC_001659 inhibits proliferation and invasion of esophageal squamous cell carcinoma cells. World J Gastroenterol 2019; 25(42): 6299-6310 [PMID: 31754291 DOI: 10.3748/wjg.v25.i42.6299] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
41 Zhao M, Wang S, Li Q, Ji Q, Guo P, Liu X. MALAT1: A long non-coding RNA highly associated with human cancers. Oncol Lett 2018;16:19-26. [PMID: 29928382 DOI: 10.3892/ol.2018.8613] [Cited by in Crossref: 21] [Cited by in F6Publishing: 45] [Article Influence: 5.3] [Reference Citation Analysis]
42 Tian B, Liu J, Zhang N, Song Y, Xu Y, Xie M, Wang B, Hua H, Shen Y, Li Y, Yang M. Oncogenic SNORD12B activates the AKT-mTOR-4EBP1 signaling in esophageal squamous cell carcinoma via nucleus partitioning of PP-1α. Oncogene 2021;40:3734-47. [PMID: 33941854 DOI: 10.1038/s41388-021-01809-2] [Reference Citation Analysis]
43 Shang C, Guo Y, Hong Y, Xue YX. Long Non-coding RNA TUSC7, a Target of miR-23b, Plays Tumor-Suppressing Roles in Human Gliomas. Front Cell Neurosci 2016;10:235. [PMID: 27766072 DOI: 10.3389/fncel.2016.00235] [Cited by in Crossref: 45] [Cited by in F6Publishing: 55] [Article Influence: 7.5] [Reference Citation Analysis]
44 Zhang X, Cheng Z, Wang L, Jiao B, Yang H, Wang X. MiR-21-3p Centric Regulatory Network in Dairy Cow Mammary Epithelial Cell Proliferation. J Agric Food Chem 2019;67:11137-47. [PMID: 31532202 DOI: 10.1021/acs.jafc.9b04059] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
45 Zehendner CM, Valasarajan C, Werner A, Boeckel JN, Bischoff FC, John D, Weirick T, Glaser SF, Rossbach O, Jaé N, Demolli S, Khassafi F, Yuan K, de Jesus Perez VA, Michalik KM, Chen W, Seeger W, Guenther A, Wasnick RM, Uchida S, Zeiher AM, Dimmeler S, Pullamsetti SS. Long Noncoding RNA TYKRIL Plays a Role in Pulmonary Hypertension via the p53-mediated Regulation of PDGFRβ. Am J Respir Crit Care Med 2020;202:1445-57. [PMID: 32634060 DOI: 10.1164/rccm.201910-2041OC] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
46 Deng HY, Wang YC, Ni PZ, Lin YD, Chen LQ. Long noncoding RNAs are novel potential prognostic biomarkers for esophageal squamous cell carcinoma: an overview. J Thorac Dis. 2016;8:E653-E659. [PMID: 27621894 DOI: 10.21037/jtd.2016.07.01] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
47 Karagkouni D, Paraskevopoulou MD, Tastsoglou S, Skoufos G, Karavangeli A, Pierros V, Zacharopoulou E, Hatzigeorgiou AG. DIANA-LncBase v3: indexing experimentally supported miRNA targets on non-coding transcripts. Nucleic Acids Res 2020;48:D101-10. [PMID: 31732741 DOI: 10.1093/nar/gkz1036] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 13.0] [Reference Citation Analysis]
48 Gholipour M, Mikaeli J, Mowla SJ, Bakhtiarizadeh MR, Saghaeian Jazi M, Javid N, Fazlollahi N, Khoshnia M, Behnampour N, Moradi A. Identification of differentially expressed microRNAs in primary esophageal achalasia by next-generation sequencing. Turk J Biol 2021;45:262-74. [PMID: 34377051 DOI: 10.3906/biy-2101-61] [Reference Citation Analysis]
49 Luo L, Wang Y, Hu P, Wu J. Long Non-Coding RNA Metastasis Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Promotes Hypertension by Modulating the Hsa-miR-124-3p/Nuclear Receptor Subfamily 3, Group C, Member 2 (NR3C2) and Hsa-miR-135a-5p/NR3C2 Axis. Med Sci Monit 2020;26:e920478. [PMID: 32222724 DOI: 10.12659/MSM.920478] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
50 Zhang J, Zhao B, Chen X, Wang Z, Xu H, Huang B. Silence of Long Noncoding RNA NEAT1 Inhibits Malignant Biological Behaviors and Chemotherapy Resistance in Gastric Cancer. Pathol Oncol Res. 2018;24:109-113. [PMID: 28401449 DOI: 10.1007/s12253-017-0233-3] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 6.6] [Reference Citation Analysis]
51 Tang LB, Ma SX, Chen ZH, Huang QY, Wu LY, Wang Y, Zhao RC, Xiong LX. Exosomal microRNAs: Pleiotropic Impacts on Breast Cancer Metastasis and Their Clinical Perspectives. Biology (Basel) 2021;10:307. [PMID: 33917233 DOI: 10.3390/biology10040307] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Naidu S, Magee P, Garofalo M. MiRNA-based therapeutic intervention of cancer. J Hematol Oncol 2015;8:68. [PMID: 26062952 DOI: 10.1186/s13045-015-0162-0] [Cited by in Crossref: 73] [Cited by in F6Publishing: 68] [Article Influence: 10.4] [Reference Citation Analysis]
53 Li CY, Zhang WW, Xiang JL, Wang XH, Li J, Wang JL. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics. Chin Med J (Engl) 2019;132:2213-22. [PMID: 31490264 DOI: 10.1097/CM9.0000000000000427] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
54 Wang D, Xu H, Wu B, Jiang S, Pan H, Wang R, Chen J. Long non‑coding RNA MALAT1 sponges miR‑124‑3p.1/KLF5 to promote pulmonary vascular remodeling and cell cycle progression of pulmonary artery hypertension. Int J Mol Med 2019;44:871-84. [PMID: 31257528 DOI: 10.3892/ijmm.2019.4256] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
55 Shen WJ, Zhang F, Zhao X, Xu J. LncRNAs and Esophageal Squamous Cell Carcinoma - Implications for Pathogenesis and Drug Development. J Cancer 2016;7:1258-64. [PMID: 27390601 DOI: 10.7150/jca.14869] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
56 Kang K, Huang YH, Li HP, Guo SM. Expression of UCA1 and MALAT1 long-chain non-coding RNAs in esophageal squamous cell carcinoma tissues is predictive of patient prognosis. Arch Med Sci 2018;14:752-9. [PMID: 30002691 DOI: 10.5114/aoms.2018.73713] [Cited by in Crossref: 1] [Cited by in F6Publishing: 14] [Article Influence: 0.3] [Reference Citation Analysis]
57 Tang X, Wang J, Zhou S, Zhou J, Jia G, Wang H, Xin C, Fu G, Zhang J. miR‑760 regulates skeletal muscle proliferation in rheumatoid arthritis by targeting Myo18b. Mol Med Rep 2019;20:4843-54. [PMID: 31661144 DOI: 10.3892/mmr.2019.10775] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
58 Zhou Y, Zheng X, Xu B, Hu W, Huang T, Jiang J. The Identification and Analysis of mRNA-lncRNA-miRNA Cliques From the Integrative Network of Ovarian Cancer. Front Genet 2019;10:751. [PMID: 31497032 DOI: 10.3389/fgene.2019.00751] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
59 Zhang Y, Miao Y, Shang M, Liu M, Liu R, Pan E, Pu Y, Yin L. LincRNA-p21 leads to G1 arrest by p53 pathway in esophageal squamous cell carcinoma. Cancer Manag Res 2019;11:6201-14. [PMID: 31308755 DOI: 10.2147/CMAR.S197557] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
60 Bhattacharyya S, Vrati S. The Malat1 long non-coding RNA is upregulated by signalling through the PERK axis of unfolded protein response during flavivirus infection. Sci Rep 2015;5:17794. [PMID: 26634309 DOI: 10.1038/srep17794] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
61 Wang Q, Yang L, Fan Y, Tang W, Sun H, Xu Z, Zhou J, Zhang Y, Zhu B, Cao X. Circ-ZDHHC5 Accelerates Esophageal Squamous Cell Carcinoma Progression in vitro via miR-217/ZEB1 Axis. Front Cell Dev Biol 2020;8:570305. [PMID: 33392180 DOI: 10.3389/fcell.2020.570305] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
62 Zhang X, Tang X, Liu K, Hamblin MH, Yin KJ. Long Noncoding RNA Malat1 Regulates Cerebrovascular Pathologies in Ischemic Stroke. J Neurosci 2017;37:1797-806. [PMID: 28093478 DOI: 10.1523/JNEUROSCI.3389-16.2017] [Cited by in Crossref: 127] [Cited by in F6Publishing: 74] [Article Influence: 25.4] [Reference Citation Analysis]
63 Miao S, Mao X, Zhao S, Song K, Xiang C, Lv Y, Jiang H, Wang L, Li B, Yang X, Yuan Z, Xiu C, Meng H, Sun J. miR-217 inhibits laryngeal cancer metastasis by repressing AEG-1 and PD-L1 expression. Oncotarget 2017;8:62143-53. [PMID: 28977933 DOI: 10.18632/oncotarget.19121] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 5.4] [Reference Citation Analysis]
64 Zhang D, Hou XL, Wu B, Li DD. Long non-coding RNAs in esophageal cancer. Shijie Huaren Xiaohua Zazhi 2015; 23(17): 2744-2753 [DOI: 10.11569/wcjd.v23.i17.2744] [Reference Citation Analysis]
65 Zhong Z, Lv M, Chen J. Screening differential circular RNA expression profiles reveals the regulatory role of circTCF25-miR-103a-3p/miR-107-CDK6 pathway in bladder carcinoma. Sci Rep 2016;6:30919. [PMID: 27484176 DOI: 10.1038/srep30919] [Cited by in Crossref: 226] [Cited by in F6Publishing: 255] [Article Influence: 37.7] [Reference Citation Analysis]
66 Nie M, Tan X, Lu Y, Wu Z, Li J, Xu D, Zhang P, You F. Network of microRNA-transcriptional factor-mRNA in cold response of turbot Scophthalmus maximus. Fish Physiol Biochem 2019;45:583-97. [PMID: 30790148 DOI: 10.1007/s10695-019-00611-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
67 Fernandes JCR, Acuña SM, Aoki JI, Floeter-Winter LM, Muxel SM. Long Non-Coding RNAs in the Regulation of Gene Expression: Physiology and Disease. Noncoding RNA 2019;5:E17. [PMID: 30781588 DOI: 10.3390/ncrna5010017] [Cited by in Crossref: 162] [Cited by in F6Publishing: 175] [Article Influence: 54.0] [Reference Citation Analysis]
68 Sun Y, Zhou Y, Bai Y, Wang Q, Bao J, Luo Y, Guo Y, Guo L. A long non-coding RNA HOTTIP expression is associated with disease progression and predicts outcome in small cell lung cancer patients. Mol Cancer 2017;16:162. [PMID: 29041935 DOI: 10.1186/s12943-017-0729-1] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 6.4] [Reference Citation Analysis]
69 Cooper DR, Wang C, Patel R, Trujillo A, Patel NA, Prather J, Gould LJ, Wu MH. Human Adipose-Derived Stem Cell Conditioned Media and Exosomes Containing MALAT1 Promote Human Dermal Fibroblast Migration and Ischemic Wound Healing. Adv Wound Care (New Rochelle) 2018;7:299-308. [PMID: 30263873 DOI: 10.1089/wound.2017.0775] [Cited by in Crossref: 55] [Cited by in F6Publishing: 62] [Article Influence: 13.8] [Reference Citation Analysis]
70 Zhao X, Chen Q, Cai Y, Chen D, Bei M, Dong H, Xu J. TRA2A Binds With LncRNA MALAT1 To Promote Esophageal Cancer Progression By Regulating EZH2/β-catenin Pathway. J Cancer 2021;12:4883-90. [PMID: 34234858 DOI: 10.7150/jca.55661] [Reference Citation Analysis]
71 Tian Y, Xu Y, Wang H, Shu R, Sun L, Zeng Y, Gong F, Lei Y, Wang K, Luo H. Comprehensive analysis of microarray expression profiles of circRNAs and lncRNAs with associated co-expression networks in human colorectal cancer. Funct Integr Genomics 2019;19:311-27. [PMID: 30446877 DOI: 10.1007/s10142-018-0641-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
72 Jiang G, Su Z, Liang X, Huang Y, Lan Z, Jiang X. Long non-coding RNAs in prostate tumorigenesis and therapy (Review). Mol Clin Oncol 2020;13:76. [PMID: 33005410 DOI: 10.3892/mco.2020.2146] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
73 Zhang J, Li Q, Xue B, He R. MALAT1 inhibits the Wnt/β-catenin signaling pathway in colon cancer cells and affects cell proliferation and apoptosis. Bosn J Basic Med Sci 2020;20:357-64. [PMID: 31733641 DOI: 10.17305/bjbms.2019.4408] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
74 Ge Y, Yan X, Jin Y, Yang X, Yu X, Zhou L, Han S, Yuan Q, Yang M. MiRNA-192 [corrected] and miRNA-204 Directly Suppress lncRNA HOTTIP and Interrupt GLS1-Mediated Glutaminolysis in Hepatocellular Carcinoma. PLoS Genet 2015;11:e1005726. [PMID: 26710269 DOI: 10.1371/journal.pgen.1005726] [Cited by in Crossref: 98] [Cited by in F6Publishing: 108] [Article Influence: 14.0] [Reference Citation Analysis]
75 Napoli S. LncRNAs and Available Databases. Methods Mol Biol 2021;2348:3-26. [PMID: 34160796 DOI: 10.1007/978-1-0716-1581-2_1] [Reference Citation Analysis]
76 Liu S, Li J, Kang L, Tian Y, Xue Y. Degradation of long non-coding RNA-CIR decelerates proliferation, invasion and migration, but promotes apoptosis of osteosarcoma cells. Cancer Cell Int 2019;19:349. [PMID: 31889901 DOI: 10.1186/s12935-019-1076-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
77 Zhu H, Lv Z, An C, Shi M, Pan W, Zhou L, Yang W, Yang M. Onco-lncRNA HOTAIR and its functional genetic variants in papillary thyroid carcinoma. Sci Rep. 2016;6:31969. [PMID: 27549736 DOI: 10.1038/srep31969] [Cited by in Crossref: 42] [Cited by in F6Publishing: 52] [Article Influence: 7.0] [Reference Citation Analysis]
78 Liu K, Huang J, Ni J, Song D, Ding M, Wang J, Huang X, Li W. MALAT1 promotes osteosarcoma development by regulation of HMGB1 via miR-142-3p and miR-129-5p. Cell Cycle 2017;16:578-87. [PMID: 28346809 DOI: 10.1080/15384101.2017.1288324] [Cited by in Crossref: 75] [Cited by in F6Publishing: 89] [Article Influence: 15.0] [Reference Citation Analysis]
79 Liu P, Yang H, Zhang J, Peng X, Lu Z, Tong W, Chen J. The lncRNA MALAT1 acts as a competing endogenous RNA to regulate KRAS expression by sponging miR-217 in pancreatic ductal adenocarcinoma. Sci Rep 2017;7:5186. [PMID: 28701723 DOI: 10.1038/s41598-017-05274-4] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 8.2] [Reference Citation Analysis]
80 Zhou W, Song F, Wu Q, Liu R, Wang L, Liu C, Peng Y, Mao S, Feng J, Chen C. miR-217 inhibits triple-negative breast cancer cell growth, migration, and invasion through targeting KLF5. PLoS One 2017;12:e0176395. [PMID: 28437471 DOI: 10.1371/journal.pone.0176395] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
81 Liang Y, Wu Y, Chen X, Zhang S, Wang K, Guan X, Yang K, Li J, Bai Y. A novel long noncoding RNA linc00460 up-regulated by CBP/P300 promotes carcinogenesis in esophageal squamous cell carcinoma. Biosci Rep 2017;37:BSR20171019. [PMID: 28939763 DOI: 10.1042/BSR20171019] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 9.2] [Reference Citation Analysis]
82 Li C, Yao W, Zhao C, Yang G, Wei J, Qi Y, Huang R, Zhao Q, Hao C. Comprehensive Analysis of lncRNAs Related to the Prognosis of Esophageal Cancer Based on ceRNA Network and Cox Regression Model. Biomed Res Int 2020;2020:3075729. [PMID: 33381546 DOI: 10.1155/2020/3075729] [Reference Citation Analysis]
83 Wang Y, Liu J, Ma J, Sun T, Zhou Q, Wang W, Wang G, Wu P, Wang H, Jiang L, Yuan W, Sun Z, Ming L. Exosomal circRNAs: biogenesis, effect and application in human diseases. Mol Cancer 2019;18:116. [PMID: 31277663 DOI: 10.1186/s12943-019-1041-z] [Cited by in Crossref: 129] [Cited by in F6Publishing: 139] [Article Influence: 43.0] [Reference Citation Analysis]
84 Yan J, Zhou X, Dang Y, Yin C, Zhang G. Prognostic role of the long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 in various cancers: A meta-analysis. Mol Clin Oncol 2016;4:100-6. [PMID: 26870366 DOI: 10.3892/mco.2015.657] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
85 Zhang X, Hamblin MH, Yin KJ. The long noncoding RNA Malat1: Its physiological and pathophysiological functions. RNA Biol 2017;14:1705-14. [PMID: 28837398 DOI: 10.1080/15476286.2017.1358347] [Cited by in Crossref: 169] [Cited by in F6Publishing: 163] [Article Influence: 33.8] [Reference Citation Analysis]
86 Wang L, Qi Y, Wang Y, Tang H, Li Z, Wang Y, Tang S, Zhu H. LncRNA MALAT1 Suppression Protects Endothelium against oxLDL-Induced Inflammation via Inhibiting Expression of MiR-181b Target Gene TOX. Oxid Med Cell Longev 2019;2019:8245810. [PMID: 31949884 DOI: 10.1155/2019/8245810] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
87 Yu F, Lu Z, Cai J, Huang K, Chen B, Li G, Dong P, Zheng J. MALAT1 functions as a competing endogenous RNA to mediate Rac1 expression by sequestering miR-101b in liver fibrosis. Cell Cycle 2015;14:3885-96. [PMID: 26697839 DOI: 10.1080/15384101.2015.1120917] [Cited by in Crossref: 75] [Cited by in F6Publishing: 70] [Article Influence: 12.5] [Reference Citation Analysis]
88 Nunvar J, Pagacova L, Vojtechova Z, Azevedo NTD, Smahelova J, Salakova M, Tachezy R. Lack of Conserved miRNA Deregulation in HPV-Induced Squamous Cell Carcinomas. Biomolecules 2021;11:764. [PMID: 34065237 DOI: 10.3390/biom11050764] [Reference Citation Analysis]
89 Chang ZW, Jia YX, Zhang WJ, Song LJ, Gao M, Li MJ, Zhao RH, Li J, Zhong YL, Sun QZ, Qin YR. LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1. J Exp Clin Cancer Res 2018;37:56. [PMID: 29530057 DOI: 10.1186/s13046-018-0724-4] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 10.3] [Reference Citation Analysis]
90 Wei L, Sun J, Zhang N, Shen Y, Wang T, Li Z, Yang M. Novel Implications of MicroRNAs, Long Non-coding RNAs and Circular RNAs in Drug Resistance of Esophageal Cancer. Front Cell Dev Biol 2021;9:764313. [PMID: 34881242 DOI: 10.3389/fcell.2021.764313] [Reference Citation Analysis]
91 Wang X, Liu H, Shi L, Yu X, Gu Y, Sun X. LINP1 facilitates DNA damage repair through non-homologous end joining (NHEJ) pathway and subsequently decreases the sensitivity of cervical cancer cells to ionizing radiation. Cell Cycle 2018;17:439-47. [PMID: 29527968 DOI: 10.1080/15384101.2018.1442625] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 6.3] [Reference Citation Analysis]
92 Gao F, Xiong X, Pan W, Yang X, Zhou C, Yuan Q, Zhou L, Yang M. A Regulatory MDM4 Genetic Variant Locating in the Binding Sequence of Multiple MicroRNAs Contributes to Susceptibility of Small Cell Lung Cancer. PLoS One 2015;10:e0135647. [PMID: 26274820 DOI: 10.1371/journal.pone.0135647] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
93 Hahne JC, Valeri N. Non-Coding RNAs and Resistance to Anticancer Drugs in Gastrointestinal Tumors. Front Oncol. 2018;8:226. [PMID: 29967761 DOI: 10.3389/fonc.2018.00226] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 7.8] [Reference Citation Analysis]
94 Xiao H, Tang K, Liu P, Chen K, Hu J, Zeng J, Xiao W, Yu G, Yao W, Zhou H, Li H, Pan Y, Li A, Ye Z, Wang J, Xu H, Huang Q. LncRNA MALAT1 functions as a competing endogenous RNA to regulate ZEB2 expression by sponging miR-200s in clear cell kidney carcinoma. Oncotarget 2015;6:38005-15. [PMID: 26461224 DOI: 10.18632/oncotarget.5357] [Cited by in Crossref: 113] [Cited by in F6Publishing: 126] [Article Influence: 18.8] [Reference Citation Analysis]
95 Fu S, Wang Y, Li H, Chen L, Liu Q. Regulatory Networks of LncRNA MALAT-1 in Cancer. Cancer Manag Res 2020;12:10181-98. [PMID: 33116873 DOI: 10.2147/CMAR.S276022] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
96 Zhang H, Wang G, Yin R, Qiu M, Xu L. [Comprehensive Identification of MicroRNAs Regulated by Long Non-coding RNA MALAT1]. Zhongguo Fei Ai Za Zhi 2016;19:247-51. [PMID: 27215451 DOI: 10.3779/j.issn.1009-3419.2016.05.11] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
97 Li X, Li X, Ren Y, Yin Z, Quan X, Xue X, Zhou B. Polymorphisms of rs1347093 and rs1397529 are associated with lung cancer risk in northeast Chinese population. Oncotarget 2017;8:94862-71. [PMID: 29212272 DOI: 10.18632/oncotarget.22030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
98 Sebastian A, Hum NR, Hudson BD, Loots GG. Cancer-Osteoblast Interaction Reduces Sost Expression in Osteoblasts and Up-Regulates lncRNA MALAT1 in Prostate Cancer. Microarrays (Basel) 2015;4:503-19. [PMID: 27600237 DOI: 10.3390/microarrays4040503] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
99 Yang Y, Alderman C, Sehlaoui A, Xiao Y, Wang W. MicroRNAs as Immunotherapy Targets for Treating Gastroenterological Cancers. Can J Gastroenterol Hepatol 2018;2018:9740357. [PMID: 30046565 DOI: 10.1155/2018/9740357] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
100 Zhou S, Xuan Z, Wang L, Ping P, Pei T. A Novel Model for Predicting Associations between Diseases and LncRNA-miRNA Pairs Based on a Newly Constructed Bipartite Network. Comput Math Methods Med 2018;2018:6789089. [PMID: 29853986 DOI: 10.1155/2018/6789089] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
101 Ragusa M, Barbagallo C, Brex D, Caponnetto A, Cirnigliaro M, Battaglia R, Barbagallo D, Di Pietro C, Purrello M. Molecular Crosstalking among Noncoding RNAs: A New Network Layer of Genome Regulation in Cancer. Int J Genomics 2017;2017:4723193. [PMID: 29147648 DOI: 10.1155/2017/4723193] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
102 Brock M, Schuoler C, Leuenberger C, Bühlmann C, Haider TJ, Vogel J, Ulrich S, Gassmann M, Kohler M, Huber LC. Analysis of hypoxia-induced noncoding RNAs reveals metastasis-associated lung adenocarcinoma transcript 1 as an important regulator of vascular smooth muscle cell proliferation. Exp Biol Med (Maywood) 2017;242:487-96. [PMID: 28056547 DOI: 10.1177/1535370216685434] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 7.6] [Reference Citation Analysis]
103 Wu Y, Lu W, Xu J, Shi Y, Zhang H, Xia D. Prognostic value of long non-coding RNA MALAT1 in cancer patients. Tumour Biol 2016;37:897-903. [PMID: 26254614 DOI: 10.1007/s13277-015-3870-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
104 Nanni S, Aiello A, Salis C, Re A, Cencioni C, Bacci L, Pierconti F, Pinto F, Ripoli C, Ostano P, Baroni S, Lazzarino G, Tavazzi B, Pugliese D, Bassi P, Grassi C, Panunzi S, Chiorino G, Pontecorvi A, Gaetano C, Farsetti A. Metabolic Reprogramming by Malat1 Depletion in Prostate Cancer. Cancers (Basel) 2020;13:E15. [PMID: 33375130 DOI: 10.3390/cancers13010015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
105 Syllaios A, Moris D, Karachaliou GS, Sakellariou S, Karavokyros I, Gazouli M, Schizas D. Pathways and role of MALAT1 in esophageal and gastric cancer. Oncol Lett 2021;21:343. [PMID: 33747200 DOI: 10.3892/ol.2021.12604] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
106 Hermans-Beijnsberger S, van Bilsen M, Schroen B. Long non-coding RNAs in the failing heart and vasculature. Noncoding RNA Res 2018;3:118-30. [PMID: 30175285 DOI: 10.1016/j.ncrna.2018.04.002] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 7.5] [Reference Citation Analysis]
107 Xue W, Zheng Y, Shen Z, Li L, Fan Z, Wang W, Zhu Z, Zhai Y, Zhao J, Kan Q. Involvement of long non-coding RNAs in the progression of esophageal cancer. Cancer Commun (Lond) 2021;41:371-88. [PMID: 33605567 DOI: 10.1002/cac2.12146] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
108 Fanelli GN, Gasparini P, Coati I, Cui R, Pakula H, Chowdhury B, Valeri N, Loupakis F, Kupcinskas J, Cappellesso R, Fassan M. LONG-NONCODING RNAs in gastroesophageal cancers. Noncoding RNA Res 2018;3:195-212. [PMID: 30533569 DOI: 10.1016/j.ncrna.2018.10.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
109 Sugihara H, Ishimoto T, Miyake K, Izumi D, Baba Y, Yoshida N, Watanabe M, Baba H. Noncoding RNA Expression Aberration Is Associated with Cancer Progression and Is a Potential Biomarker in Esophageal Squamous Cell Carcinoma. Int J Mol Sci. 2015;16:27824-27834. [PMID: 26610479 DOI: 10.3390/ijms161126060] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
110 Jiang L, Chen Q, Bei M, Shao M, Xu J. Characterizing the tumor RBP-ncRNA circuits by integrating transcriptomics, interactomics and clinical data. Comput Struct Biotechnol J 2021;19:5235-45. [PMID: 34630941 DOI: 10.1016/j.csbj.2021.09.019] [Reference Citation Analysis]
111 McCown PJ, Wang MC, Jaeger L, Brown JA. Secondary Structural Model of Human MALAT1 Reveals Multiple Structure-Function Relationships. Int J Mol Sci 2019;20:E5610. [PMID: 31717552 DOI: 10.3390/ijms20225610] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
112 Jen J, Tang YA, Lu YH, Lin CC, Lai WW, Wang YC. Oct4 transcriptionally regulates the expression of long non-coding RNAs NEAT1 and MALAT1 to promote lung cancer progression. Mol Cancer 2017;16:104. [PMID: 28615056 DOI: 10.1186/s12943-017-0674-z] [Cited by in Crossref: 82] [Cited by in F6Publishing: 93] [Article Influence: 16.4] [Reference Citation Analysis]
113 Yang J, Hou S, Liang B. LINC00319 promotes migration, invasion and epithelial-mesenchymal transition process in cervical cancer by regulating miR-3127-5p/RPP25 axis. In Vitro Cell Dev Biol Anim 2020;56:145-53. [PMID: 31942724 DOI: 10.1007/s11626-019-00425-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
114 Wang J, Sun G. FOXO1-MALAT1-miR-26a-5p Feedback Loop Mediates Proliferation and Migration in Osteosarcoma Cells. Oncol Res 2017;25:1517-27. [PMID: 28160461 DOI: 10.3727/096504017X14859934460780] [Cited by in Crossref: 26] [Cited by in F6Publishing: 14] [Article Influence: 5.2] [Reference Citation Analysis]
115 Zhuo M, Yuan C, Han T, Cui J, Jiao F, Wang L. A novel feedback loop between high MALAT-1 and low miR-200c-3p promotes cell migration and invasion in pancreatic ductal adenocarcinoma and is predictive of poor prognosis. BMC Cancer 2018;18:1032. [PMID: 30352575 DOI: 10.1186/s12885-018-4954-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
116 Zhou X, Liu S, Cai G, Kong L, Zhang T, Ren Y, Wu Y, Mei M, Zhang L, Wang X. Long Non Coding RNA MALAT1 Promotes Tumor Growth and Metastasis by inducing Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma. Sci Rep 2015;5:15972. [PMID: 26522444 DOI: 10.1038/srep15972] [Cited by in Crossref: 146] [Cited by in F6Publishing: 151] [Article Influence: 20.9] [Reference Citation Analysis]
117 Abraham JM, Meltzer SJ. Long Noncoding RNAs in the Pathogenesis of Barrett's Esophagus and Esophageal Carcinoma. Gastroenterology 2017;153:27-34. [PMID: 28528706 DOI: 10.1053/j.gastro.2017.04.046] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
118 Dai X, Chen C, Yang Q, Xue J, Chen X, Sun B, Luo F, Liu X, Xiao T, Xu H, Sun Q, Zhang A, Liu Q. Exosomal circRNA_100284 from arsenite-transformed cells, via microRNA-217 regulation of EZH2, is involved in the malignant transformation of human hepatic cells by accelerating the cell cycle and promoting cell proliferation. Cell Death Dis 2018;9:454. [PMID: 29674685 DOI: 10.1038/s41419-018-0485-1] [Cited by in Crossref: 73] [Cited by in F6Publishing: 72] [Article Influence: 18.3] [Reference Citation Analysis]
119 Xiong Z, Wang L, Wang Q, Yuan Y. LncRNA MALAT1/miR-129 axis promotes glioma tumorigenesis by targeting SOX2. J Cell Mol Med 2018. [PMID: 29808528 DOI: 10.1111/jcmm.13667] [Cited by in Crossref: 33] [Cited by in F6Publishing: 40] [Article Influence: 8.3] [Reference Citation Analysis]
120 Tian X, Xu G. Clinical value of lncRNA MALAT1 as a prognostic marker in human cancer: systematic review and meta-analysis. BMJ Open. 2015;5:e008653. [PMID: 26423854 DOI: 10.1136/bmjopen-2015-008653] [Cited by in Crossref: 78] [Cited by in F6Publishing: 84] [Article Influence: 11.1] [Reference Citation Analysis]
121 Arun G, Aggarwal D, Spector DL. MALAT1 Long Non-Coding RNA: Functional Implications. Noncoding RNA 2020;6:E22. [PMID: 32503170 DOI: 10.3390/ncrna6020022] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 12.0] [Reference Citation Analysis]
122 Karagkouni D, Karavangeli A, Paraskevopoulou MD, Hatzigeorgiou AG. Characterizing miRNA-lncRNA Interplay. Methods Mol Biol 2021;2372:243-62. [PMID: 34417757 DOI: 10.1007/978-1-0716-1697-0_21] [Reference Citation Analysis]
123 Radwan AF, Shaker OG, El-Boghdady NA, Senousy MA. Association of MALAT1 and PVT1 Variants, Expression Profiles and Target miRNA-101 and miRNA-186 with Colorectal Cancer: Correlation with Epithelial-Mesenchymal Transition. Int J Mol Sci 2021;22:6147. [PMID: 34200314 DOI: 10.3390/ijms22116147] [Reference Citation Analysis]
124 Zhao X, Chen D, Cai Y, Zhang F, Xu J. RBPvsMIR: A Computational Pipeline to Identify Competing miRNAs and RNA-Binding Protein Pairs Regulating the Shared Transcripts. Genes (Basel) 2018;9:E426. [PMID: 30131454 DOI: 10.3390/genes9090426] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
125 Shuai P, Zhou Y, Gong B, Jiang Z, Yang C, Yang H, Zhang D, Zhu S. Long noncoding RNA MALAT1 can serve as a valuable biomarker for prognosis and lymph node metastasis in various cancers: a meta-analysis. Springerplus 2016;5:1721. [PMID: 27777857 DOI: 10.1186/s40064-016-3342-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
126 Luo W, He H, Xiao W, Liu Q, Deng Z, Lu Y, Wang Q, Zheng Q, Li Y. MALAT1 promotes osteosarcoma development by targeting TGFA via MIR376A. Oncotarget 2016;7:54733-43. [PMID: 27458156 DOI: 10.18632/oncotarget.10752] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 9.5] [Reference Citation Analysis]
127 Lu H, He Y, Lin L, Qi Z, Ma L, Li L, Su Y. Long non-coding RNA MALAT1 modulates radiosensitivity of HR-HPV+ cervical cancer via sponging miR-145. Tumour Biol 2016;37:1683-91. [PMID: 26311052 DOI: 10.1007/s13277-015-3946-5] [Cited by in Crossref: 82] [Cited by in F6Publishing: 86] [Article Influence: 11.7] [Reference Citation Analysis]
128 Zhang FF, Luo YH, Wang H, Zhao L. Metastasis-associated long noncoding RNAs in gastrointestinal cancer: Implications for novel biomarkers and therapeutic targets. World J Gastroenterol 2016; 22(39): 8735-8749 [PMID: 27818589 DOI: 10.3748/wjg.v22.i39.8735] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
129 Wang Y, Mou Q, Zhu Z, Zhao L, Zhu L. MALAT1 promotes liver fibrosis by sponging miR‑181a and activating TLR4‑NF‑κB signaling. Int J Mol Med 2021;48:215. [PMID: 34651657 DOI: 10.3892/ijmm.2021.5048] [Reference Citation Analysis]
130 Kulkarni P, Dasgupta P, Bhat NS, Shahryari V, Shiina M, Hashimoto Y, Majid S, Deng G, Saini S, Tabatabai ZL, Yamamura S, Tanaka Y, Dahiya R. Elevated miR-182-5p Associates with Renal Cancer Cell Mitotic Arrest through Diminished MALAT-1 Expression. Mol Cancer Res. 2018;16:1750-1760. [PMID: 30037856 DOI: 10.1158/1541-7786.mcr-17-0762] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
131 Lei R, Xue M, Zhang L, Lin Z. Long noncoding RNA MALAT1-regulated microRNA 506 modulates ovarian cancer growth by targeting iASPP. Onco Targets Ther 2017;10:35-46. [PMID: 28031721 DOI: 10.2147/OTT.S112686] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 6.3] [Reference Citation Analysis]
132 Jiang C, Li X, Zhao H, Liu H. Long non-coding RNAs: potential new biomarkers for predicting tumor invasion and metastasis. Mol Cancer 2016;15:62. [PMID: 27686732 DOI: 10.1186/s12943-016-0545-z] [Cited by in Crossref: 104] [Cited by in F6Publishing: 109] [Article Influence: 17.3] [Reference Citation Analysis]
133 Youness RA, Gad MZ. Long non-coding RNAs: Functional regulatory players in breast cancer. Noncoding RNA Res 2019;4:36-44. [PMID: 30891536 DOI: 10.1016/j.ncrna.2019.01.003] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 13.3] [Reference Citation Analysis]
134 Li F, Li X, Qiao L, Liu W, Xu C, Wang X. MALAT1 regulates miR-34a expression in melanoma cells. Cell Death Dis 2019;10:389. [PMID: 31101802 DOI: 10.1038/s41419-019-1620-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]